• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸癌中的肿瘤标志物。

Tumor markers in testis cancer.

作者信息

Klein E A

机构信息

Department of Urology, Cleveland Clinic Foundation, Ohio.

出版信息

Urol Clin North Am. 1993 Feb;20(1):67-73.

PMID:7679533
Abstract

Human chorionic gonadotropin and alpha-fetoprotein are well established as serum markers for germ-cell tumors of the testis. Other protein markers of this disease are lactic acid dehydrogenase and placental alkaline phosphatase. There also are cytogenetic or chromosomal markers, particularly i(12p), and molecular markers in the form of oncogenes and tumor suppressor genes. Markers are valuable in diagnosis, staging, predicting tumor behavior, and monitoring therapy and disease recurrence.

摘要

人绒毛膜促性腺激素和甲胎蛋白是睾丸生殖细胞肿瘤公认的血清标志物。该疾病的其他蛋白质标志物包括乳酸脱氢酶和胎盘碱性磷酸酶。也存在细胞遗传学或染色体标志物,特别是i(12p),以及以癌基因和肿瘤抑制基因形式存在的分子标志物。标志物在诊断、分期、预测肿瘤行为以及监测治疗和疾病复发方面具有重要价值。

相似文献

1
Tumor markers in testis cancer.睾丸癌中的肿瘤标志物。
Urol Clin North Am. 1993 Feb;20(1):67-73.
2
Tumor markers in testicular cancer--an update.睾丸癌中的肿瘤标志物——最新进展
Prog Clin Biol Res. 1985;203:141-54.
3
[Usefulness of tumor markers in the treatment of germ cell tumors].
Arch Esp Urol. 2000 Jul-Aug;53(6):460-8.
4
[The role of tumor markers in the treatment of germ cell tumor].[肿瘤标志物在生殖细胞肿瘤治疗中的作用]
Gan To Kagaku Ryoho. 2001 Aug;28(8):1159-65.
5
[Testis cancer markers. Clinical use].[睾丸癌标志物。临床应用]
Minerva Med. 2002 Oct;93(5):365-9.
6
Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.甲胎蛋白、人绒毛膜促性腺激素和乳酸脱氢酶标志物在晚期生殖细胞肿瘤细胞减灭术前后的诊断价值 分别地
Prog Clin Biol Res. 1985;203:107-16.
7
Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
J Urol. 2000 Nov;164(5):1670.
8
Tumor markers in testicular cancer.睾丸癌中的肿瘤标志物
Urol Clin North Am. 1979 Oct;6(3):613-28.
9
[The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].[肿瘤标志物在非精原细胞瘤Ⅲ至Ⅳ期睾丸肿瘤中的诊断及预后价值]
Urol Nefrol (Mosk). 1989 May-Jun(3):42-6.
10
Management of seminoma based on tumor markers.基于肿瘤标志物的精原细胞瘤管理。
Urol Clin North Am. 1980 Oct;7(3):773-81.

引用本文的文献

1
A Review in Management of Testicular Cancer: Single Center Review.睾丸癌管理综述:单中心综述
World J Oncol. 2011 Jun;2(3):94-101. doi: 10.4021/wjon258w. Epub 2011 Jun 8.
2
Clinically Meaningful Use of Blood Tumor Markers in Oncology.血液肿瘤标志物在肿瘤学中的临床意义性应用。
Biomed Res Int. 2016;2016:9795269. doi: 10.1155/2016/9795269. Epub 2016 Nov 30.
3
Tumour markers and kidney function: a systematic review.肿瘤标志物与肾功能:一项系统综述。
Biomed Res Int. 2014;2014:647541. doi: 10.1155/2014/647541. Epub 2014 Feb 6.
4
A human monoclonal antibody specific to placental alkaline phosphatase, a marker of ovarian cancer.一种针对胎盘碱性磷酸酶的人源单克隆抗体,该酶是卵巢癌的标志物。
MAbs. 2014 Jan-Feb;6(1):86-94. doi: 10.4161/mabs.27230.
5
Current management of testicular cancer.睾丸癌的当前管理
Korean J Urol. 2013 Jan;54(1):2-10. doi: 10.4111/kju.2013.54.1.2. Epub 2013 Jan 18.
6
Characteristics of thymoma successfully resected by videothoracoscopic surgery.经电视胸腔镜手术成功切除的胸腺瘤的特征
Surg Today. 2007;37(3):192-6. doi: 10.1007/s00595-006-3383-6. Epub 2007 Mar 9.
7
125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.125I标记的人绒毛膜促性腺激素(hCG)作为消除标志物,用于评估睾丸癌患者化疗期间hCG的下降情况。
Br J Cancer. 1999 Jul;80(10):1577-81. doi: 10.1038/sj.bjc.6690565.
8
Oncogenes in tumor metabolism, tumorigenesis, and apoptosis.肿瘤代谢、肿瘤发生及细胞凋亡中的癌基因。
J Bioenerg Biomembr. 1997 Aug;29(4):345-54. doi: 10.1023/a:1022446730452.
9
Management of testicular cancer with combined-modality treatment.睾丸癌的综合治疗管理
Int Urol Nephrol. 1995;27(4):423-9. doi: 10.1007/BF02550078.
10
Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy.
Int Urol Nephrol. 1995;27(3):325-9. doi: 10.1007/BF02564770.